UA118497C2 - METHOD OF TREATMENT OF CHILDREN WITH SPINAL MUSCLE ATROPHY TYPE III BY PREPARATIONS OF MATERIAL OF EMBRYOPHETAL ORIGIN AND ILLUSTRATED FROM - Google Patents

METHOD OF TREATMENT OF CHILDREN WITH SPINAL MUSCLE ATROPHY TYPE III BY PREPARATIONS OF MATERIAL OF EMBRYOPHETAL ORIGIN AND ILLUSTRATED FROM

Info

Publication number
UA118497C2
UA118497C2 UAA201704100A UAA201704100A UA118497C2 UA 118497 C2 UA118497 C2 UA 118497C2 UA A201704100 A UAA201704100 A UA A201704100A UA A201704100 A UAA201704100 A UA A201704100A UA 118497 C2 UA118497 C2 UA 118497C2
Authority
UA
Ukraine
Prior art keywords
type iii
children
stem cells
embryophetal
preparations
Prior art date
Application number
UAA201704100A
Other languages
Ukrainian (uk)
Inventor
Наталія Сергіївна Сич
Марія Петрівна Демчук
Ірина Георгіївна Матіящук
Марія Олексіївна Клунник
Олена Віталіївна Іванкова
Марина Вікторівна Скалозуб
Андрій Аркадійович Сінельник
Христина Ігорівна Сорочинська
Original Assignee
Товариство З Обмеженою Відповідальністю "Центр Ембріональних Тканин "Емселл"
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Товариство З Обмеженою Відповідальністю "Центр Ембріональних Тканин "Емселл" filed Critical Товариство З Обмеженою Відповідальністю "Центр Ембріональних Тканин "Емселл"
Priority to UAA201704100A priority Critical patent/UA118497C2/en
Publication of UA118497C2 publication Critical patent/UA118497C2/en

Links

Landscapes

  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Винахід належить до способу лікування дітей зі спінальною м'язовою атрофією III типу, шляхом приготування та введення щонайменше двох препаратів з матеріалу ембріофетального походження та виділених з нього клітин, де перший препарат являє собою суспензію стовбурових клітин з фетальної печінки, та другий препарат являє собою суспензію стовбурових клітини фетального головного мозку, причому вказані суспензії стовбурових клітин вводять одночасно з проведенням стандартної терапії, а перед введенням суспензії стовбурових клітин з фетальної печінки додатково виконують премедикацію.The invention relates to a method of treating children with spinal muscular atrophy type III, by preparing and administering at least two drugs from embryo-fetal material and isolated cells, where the first drug is a suspension of stem cells from fetal liver, and the second drug is a suspension fetal brain stem cells, and these suspensions of stem cells are administered simultaneously with standard therapy, and before the introduction of a suspension of stem cells from the fetal liver additionally perform premedication.

UAA201704100A 2017-04-25 2017-04-25 METHOD OF TREATMENT OF CHILDREN WITH SPINAL MUSCLE ATROPHY TYPE III BY PREPARATIONS OF MATERIAL OF EMBRYOPHETAL ORIGIN AND ILLUSTRATED FROM UA118497C2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
UAA201704100A UA118497C2 (en) 2017-04-25 2017-04-25 METHOD OF TREATMENT OF CHILDREN WITH SPINAL MUSCLE ATROPHY TYPE III BY PREPARATIONS OF MATERIAL OF EMBRYOPHETAL ORIGIN AND ILLUSTRATED FROM

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
UAA201704100A UA118497C2 (en) 2017-04-25 2017-04-25 METHOD OF TREATMENT OF CHILDREN WITH SPINAL MUSCLE ATROPHY TYPE III BY PREPARATIONS OF MATERIAL OF EMBRYOPHETAL ORIGIN AND ILLUSTRATED FROM

Publications (1)

Publication Number Publication Date
UA118497C2 true UA118497C2 (en) 2019-01-25

Family

ID=74214458

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA201704100A UA118497C2 (en) 2017-04-25 2017-04-25 METHOD OF TREATMENT OF CHILDREN WITH SPINAL MUSCLE ATROPHY TYPE III BY PREPARATIONS OF MATERIAL OF EMBRYOPHETAL ORIGIN AND ILLUSTRATED FROM

Country Status (1)

Country Link
UA (1) UA118497C2 (en)

Similar Documents

Publication Publication Date Title
MX2019011215A (en) Nucleic acids encoding crispr-associated proteins and uses thereof.
EA201890725A1 (en) PHARNESIDE X-RECEPTOR AGONISTS AND THEIR APPLICATION
MY191040A (en) Therapy involving antibodies against claudin 18.2 for treatment of cancer
AU2017291414B2 (en) Anti-N3pGLu amyloid beta peptide antibodies and uses thereof
MX2016009231A (en) Administration of tasimelteon under fasted conditions.
EA201992083A1 (en) SOMATOSTATIN MODULATORS AND THEIR APPLICATION
EA201791535A1 (en) NEW CONNECTION 4'-TIONOUCLEOSIDE, AND ALSO THE WAY OF ITS OBTAINING, ITS PHARMACEUTICAL COMPOSITION AND APPLICATION
RU2017134443A (en) METHOD OF TREATMENT WITH USE OF TRADIPTANT
EA202290024A1 (en) METHODS FOR THE TREATMENT OF FABRY DISEASE IN PATIENTS WITH RENAL INSUFFICIENCY
JOP20210323A1 (en) Multispecific heavy chain antibodies binding to cd22 and cd3
MX2022004678A (en) Anti-beta-amyloid antibody for treating alzheimer's disease.
BR112019006216A2 (en) p2x3 and / or p2x2 / 3 compounds and methods
EA202092540A1 (en) COMBINATIONS FOR CANCER TREATMENT
UA118497C2 (en) METHOD OF TREATMENT OF CHILDREN WITH SPINAL MUSCLE ATROPHY TYPE III BY PREPARATIONS OF MATERIAL OF EMBRYOPHETAL ORIGIN AND ILLUSTRATED FROM
JOP20190019A1 (en) PHARMACEUTICAL COMPOSITION FOR TREATING GROWTH HORMONE DEFICIENCY CONTAINING hGH FUSION PROTEIN
MX2022004382A (en) Methods of promoting scfa production by gut microbiota.
WO2016130518A3 (en) Methods and compositions for treating muscle disease and disorders
MX2021008081A (en) Treatment of sjogren's disease with nuclease fusion proteins.
MX2021006242A (en) Capsule formulations.
WO2020086479A9 (en) Dosing
CA3199014A1 (en) Combination therapy for the treatment of a liver disease
JOP20170044B1 (en) Pharmaceutical composition comprising recombinant hgh for the treatment of growth hormone deficiency
MX2021015338A (en) Composition comprising pridopidine and analog thereof for treating huntington disease and symptoms thereof.
AU2020360413A8 (en) Methods of treating conditions related to the S1P1 receptor
WO2021099966A3 (en) Novel benzothiophene derivatives and use thereof for stimulating mitochondrial turnover